Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Please,please explain tell me this is not more excellent news. The sp really cannot cope.
Fibonacci, potential support levels are 38.2%, at 6.4, and 50%, at 6.0. The previous major price peak , of November 2023, high price was 6.25, which provides an area of potential support. The current retracement was signalled, when the volatility based lower bollinger band first turned upwards. However the upper bollinger band moving upwards indicates the major trend is upwards, so the retracement, will end soon, likely with the sp, zone of 6 to 6.4. DYOR.
Dilution then
Must be the only outfit that sees a share dip after "excellent" news. That has become the norm at Kromek.
Trend line still in play. Short little uprise with bigger sells than buys and down we go again. Possible .0275 coming and not far away either.
Excellent news. Thanks for posting.
Of little interest to shareholders ! "same old " story.
Pedro, i respect your opinion. Question in your opinion why do Basu and the BOD not invest in Kromek at any price ? a bargain surely at 3p and hopefully you are correct in suggesting a bargain at 8p I wonder why they do not share your optimism, what do they know that we do not ?
It will get to 30p purely on demand for product and those with history of losing money need to realise the company is different to the cash guzzling company awaiting the point of profit.the point of profit has arrived,and the future looks increasingly good from here.Demand for product will only multiply in my opinion.
Hopefully it won’t go to 30p a share via 10 for 1 consolidation!
Pedro,
Investors are now realising they value (correctly or incorrectly) this is valued at 7-8p. Next week it might be 10p, it might be 6p.
If you are correct pedro why do Basu and his chums not invest As for 30p well that is the stuff of dreams Do you predict this outfit paying a dividend also ?
I said at 3p that this would go to 30p,getting there,but, a long way to carry on up. Totally undervalued as Investors are now realising.
Agree IK. The BOD not interested even at the all-time low. Totally baffling.
Billyb, Maybe those shrewd enough to buy in at around 4p are taking the money and running. Basu and his BOD missed out there. Seems they will not buy in at ANY price.
Dumbolina.
The new CFO seemed to have forced change to a greater focus on cash and costs, standard but missing under Bulmer.
Interesting the use of ebitda, Buffett correctly believes ignoring some costs in a business doesn't represent reality.
More importantly there is a real issue in not treating capitalisation and amortization in the same way and taken out. So include capitalisation to increase profit and ignore amortization to increase profit.
Considerably more sells than buys today. Is the trendy spike over now? Just wondering.
With loan note holders having the opportunity to convert into stock it is absolutely in shareholder interests for Basu to be talking up our stock!
The momentum is with us for a change. Long may it continue.
HXXps://www.proactiveinvestors.co.uk/companies/news/1040013/kromek-group-s-positive-trajectory-insights-from-ceo-arnab-basu-icymi-1040013.html
....
Stephen Gunnion (SG): Arnab, Kromek's interim results indicate a strong first half with notable financial improvements. Can you elaborate on these achievements?
Arnab Basu (AB): Absolutely, Stephen. We've experienced a period of positive momentum, underpinned by a significant improvement in our EBITDA position and reduced pre-tax losses.
This success stems from our unwavering focus on profitability, achieved through diligent cost control and enhancing our business margins. Our growth has been particularly robust in the advanced imaging and CBRN segments, reflecting our alignment with market demands and our strategic initiatives in these areas.
SG: Could you dive deeper into the growth drivers within your main business segments?
AB: Certainly. Our advanced imaging segment, especially in SPECT and CT modalities, has seen increasing adoption of our CZT material, revolutionizing digital spectrums and enhancing diagnostic capabilities. This trend is underscored by new product launches and significant partnerships, such as our collaboration with a CT Original Equipment Manufacturer (OEM) and Spectrum Dynamics' launch of a new product.
On the CBRN front, global security concerns have spiked demand for our handheld radiation detection tools. Our contract wins and robust pipelines in this segment, alongside partnerships for biosecurity projects with the US and UK governments, mark our strategic advancements and readiness to meet evolving market needs.
SG: With the momentum built in the first half, how do you anticipate this will impact Kromek's performance moving into the full year 2024?
AB: The trajectory we've set in the first half is expected to continue, with the second half traditionally being stronger for us. We're on track to achieve record revenues, a testament to our growth strategy's effectiveness.
Our focus remains on cost control and margin improvement, positioning us to report not only significant revenue growth but also a positive EBITDA for the year. This marks a pivotal step towards our long-term profitability and underscores our commitment to delivering value.
Just register here to read:
https://www.kromek.com/investor-relations/research/
Secular downtrend from 30/7/21, broken which is bullish, and sp, has broken above previous two price peaks, which confirms the bullish scenario. The RSI(relative strength index), is approaching the overbought region, of previous RSI, highs. However volatility based Bollinger bands are separating, signifying a fast sp, movement. If the lower Bollinger band which is currently going down, begins to turnup, expect a possible retracement, in sp.
Do you have link pls?
Interesting Cavendish note today with value up to 50p on a number of measurements.
GLA
Another bit of radiation detectors news and recognition.
At the Kmk webcast last week it was stated the Kmks handheld detectors were the fastest and most sensitive commercially available.today and that they have had an AI dept for some time working along side others depts.
All good news and recognition of Kmk advanced tech.